TrialArthritis and rheumatism2008

A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Arnold E Postlethwaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.